Qube Research & Technologies (QRT)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,933,131
| Closed | -$45.1M | – | 3215 |
|
|
2025
Q1 | $45.1M | Buy |
2,933,131
+1,580,349
| +117% | +$24.3M | 0.05% | 319 |
|
|
2024
Q4 | $29.8M | Buy |
1,352,782
+126,145
| +10% | +$2.78M | 0.04% | 408 |
|
|
2024
Q3 | $22.1M | Sell |
1,226,637
-857,362
| -41% | -$15.4M | 0.03% | 462 |
|
|
2024
Q2 | $33.9M | Buy |
2,083,999
+2,022,219
| +3,273% | +$32.9M | 0.05% | 340 |
|
|
2024
Q1 | $872K | Buy |
+61,780
| New | +$872K | ﹤0.01% | 1899 |
|
|
2023
Q3 | – | Sell |
-1,618,232
| Closed | -$12.2M | – | 3897 |
|
|
2023
Q2 | $12.2M | Buy |
1,618,232
+226,841
| +16% | +$1.71M | 0.04% | 445 |
|
|
2023
Q1 | $12.3M | Buy |
+1,391,391
| New | +$12.3M | 0.05% | 375 |
|
|
2022
Q4 | – | Sell |
-2,216,584
| Closed | -$17.9M | – | 2921 |
|
|
2022
Q3 | $17.9M | Buy |
2,216,584
+1,933,334
| +683% | +$15.6M | 0.11% | 246 |
|
|
2022
Q2 | $2.13M | Buy |
+283,250
| New | +$2.13M | 0.02% | 768 |
|
|
2021
Q3 | – | Sell |
-348,175
| Closed | -$3.45M | – | 2759 |
|
|
2021
Q2 | $3.45M | Buy |
+348,175
| New | +$3.45M | 0.04% | 518 |
|
|
2020
Q4 | – | Sell |
-60,196
| Closed | -$542K | – | 2189 |
|
|
2020
Q3 | $542K | Sell |
60,196
-116,487
| -66% | -$1.05M | 0.01% | 998 |
|
|
2020
Q2 | $2.18M | Buy |
+176,683
| New | +$2.18M | 0.03% | 631 |
|